by John Conrad | Sep 17, 2024 | iBIO News
We are thrilled to announce the successful completion of the EPIC (Employer Provided Innovation Challenges) project, an initiative driven by the US Chamber of Commerce Foundation designed to provide students with hands-on, real-world learning experiences. In...
by John Conrad | Sep 12, 2024 | Policy News
In a recent hearing, the Health Care Availability & Accessibility Committee delved into the complex world of Pharmacy Benefit Managers (PBMs) and specialty pharmacies, exposing a web of concerns affecting patient care and drug pricing. The hearing, which brought...
by John Conrad | Sep 11, 2024 | NewsBrief
In a significant development for the healthcare industry, Chicago-based 32 Biosciences has announced its emergence from stealth mode, unveiling a groundbreaking approach to gut microbiome medicine. The company, whose name is pronounced “Three Squared...
by John Conrad | Sep 10, 2024 | iBIO News, Policy News
iBIO has joined forces with fellow members of the Council of State Bioscience Associations (CSBA) in a crucial initiative to safeguard the future of rare pediatric disease research and treatment. Yesterday, our coalition sent a letter to congressional leaders, urging...
by John Conrad | Sep 9, 2024 | iBIO News
Amy Tomasulo battles trigeminal neuralgia, a rare neurological disorder that inflicts some of the most excruciating pain known to medicine. Diagnosed in 2001, she lives with a condition that affects approximately 400,000 Americans, causing intense, shock-like facial...
